Remgro Stock

Remgro Operating Expenses

The Total Operating Expenses of Remgro (REM.JO) as of Aug 23, 2026 is 17.45 B ZAR. In the previous year, Total Operating Expenses was 17.11 B ZAR — a change of 1.95% (higher).

Operating Expenses

17.45 BZAR

YoY

1.95%

Last updated:

Total Operating Expenses of Remgro is 2026 17.45 B ZAR. Total Operating Expenses of Remgro was 2025 17.11 B ZAR. It decreases by 1.95% higher compared to the previous year.

The Remgro Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2018
12.04 B ZAR
Jan 1, 2019
20.08 B ZAR
Jan 1, 2020
20.89 B ZAR
Jan 1, 2021
22.96 B ZAR
Jan 1, 2022
24.96 B ZAR
Jan 1, 2023
16.44 B ZAR
Jan 1, 2024
17.11 B ZAR
Jan 1, 2025
17.45 B ZAR
The Remgro Operating Expenses history
YEAROperating ExpensesYoY
17.45 BZAR+1.95%
17.11 BZAR+4.11%
16.44 BZAR-34.14%
24.96 BZAR+8.69%
22.96 BZAR+9.91%
20.89 BZAR+4.04%
20.08 BZAR+66.82%
12.04 BZAR+12.52%
10.70 BZAR+4.62%
10.23 BZAR+16.72%
8.76 BZAR+2.15%
8.58 BZAR
Access this data via the Eulerpool API

Remgro Stock analysis

What does Remgro do? Remgro Ltd is a diversified company that offers a wide range of products and services in various business sectors. The company was founded in 1990 and is based in Stellenbosch, South Africa. The company emerged from the acquisition of Rembrandt Group Ltd, which was founded by South African billionaire and philanthropist Anton Rupert. Remgro has been a diversified company since its inception, operating in various business sectors. The company is divided into three main areas: finance, healthcare, and infrastructure. Some of the key holdings of Remgro in the finance sector include FirstRand Limited, RMB Holdings Limited, and Momentum Metropolitan Holdings Limited. In the healthcare sector, Remgro is active through its subsidiaries Mediclinic International plc and Erste Holdings Limited. Mediclinic operates clinics and hospitals in South Africa, the UK, and the UAE, offering a wide range of medical services. Erste Holdings is one of the largest pharmaceutical companies in South Africa, producing a wide range of medications and healthcare products. In the infrastructure sector, Remgro is involved through its stake in South African utility company PowerX, which is a leading provider of electricity and water in the country. Overall, Remgro is a diversified company operating in various sectors and offering a wide range of products and services. Remgro is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Remgro stock

Total Operating Expenses of Remgro is 17.45 B ZAR in 2026.

Total Operating Expenses of Remgro changed from 17.11 B ZAR to 17.45 B ZAR, representing a 1.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses Remgro since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's ZAR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's Remgro historically and in real time.

Access this data via the Eulerpool API

Income Statement — Remgro

All Key Metrics — Remgro